Effective and robust plasmid topology analysis and the subsequent characterization of the plasmid isoforms thereby observed.
Within the biopharmaceutical industry, recombinant plasmid DNA is used both as a raw material (e.g. in lentiviral and AAV vector production) as well as an active ingredient (e.g. in DNA vaccines). Consequently, many analytical laboratories are routinely involved with plasmid DNA topoisoform qualitative analysis and quantification. In order to reliably determine plasmid topology, one must ensure that the methodology employed can reliably, precisely and accurately measure qualitatively and quantitatively all topological isoforms. Presented here are an anion-exchange high-performance liquid chromatography (AEC) and an agarose gel electrophoresis (AGE)-based method developed for this purpose. The strategies undertaken to overcome the respective typical problems of limited linear range of quantitation (for AGE) and isoform resolution (for AEC) are described. Also presented is a subsequent direct comparison (for assay precision/accuracy) of these two methods, as well as a package of species characterization [by chloroquine-AGE, enzymatic digestion, multi-angle laser light-scattering (MALLS) and electron microscopy] undertaken to confirm the identity of a minor supercoiled dimeric concatamer observed by both approaches.
Molloy
Michael J
MJ
Department of Analytical Sciences, Biopharmaceutical Centre of Excellence for Drug Discovery (Beckenham), GlaxoSmithKline, Beckenham, Kent BR3 3BS, UK.
Hall
Valerie S
VS
Bailey
Susannah I
SI
Griffin
Katharine J
KJ
Faulkner
Jim
J
Uden
Mark
M
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D004278:DNA, Superhelical / Q000737:chemistry; D004587:Electrophoresis, Agar Gel / Q000379:methods*; D010957:Plasmids / Q000737:chemistry* / Q000302:isolation & purification / Q000648:ultrastructure
D004278:DNA, Superhelical